Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.

Murata Y, Tanzawa S, Misumi T, Yoshioka H, Miyauchi E, Ninomiya K, Takeshita M, Ito K, Okamoto T, Sugawara S, Kawashima Y, Hashimoto K, Mori M, Miyanaga A, Hayashi A, Tanaka H, Honda R, Nojiri M, Sato Y, Hata A, Masuda K, Kozuki T, Kawamura T, Suzuki T, Yamaguchi T, Asada K, Tetsumoto S, Tanaka H, Watanabe S, Umeda Y, Yamaguchi K, Kuyama S, Tsuruno K, Misumi Y, Kuraishi H, Yoshihara K, Nakao A, Kubo A, Yokoyama T, Watanabe K, Seki N

Open source

DOI
10.1016/j.jtocrr.2023.100593
Published
2023 Dec
Container
JTO clinical and research reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtocrr.2023.100593,
  title = {Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.},
  author = {Murata Y and Tanzawa S and Misumi T and Yoshioka H and Miyauchi E and Ninomiya K and Takeshita M and Ito K and Okamoto T and Sugawara S and Kawashima Y and Hashimoto K and Mori M and Miyanaga A and Hayashi A and Tanaka H and Honda R and Nojiri M and Sato Y and Hata A and Masuda K and Kozuki T and Kawamura T and Suzuki T and Yamaguchi T and Asada K and Tetsumoto S and Tanaka H and Watanabe S and Umeda Y and Yamaguchi K and Kuyama S and Tsuruno K and Misumi Y and Kuraishi H and Yoshihara K and Nakao A and Kubo A and Yokoyama T and Watanabe K and Seki N},
  year = {2023},
  journal = {JTO clinical and research reports},
  doi = {10.1016/j.jtocrr.2023.100593},
  url = {https://doi.org/10.1016/j.jtocrr.2023.100593}
}

RIS

TY  - JOUR
TI  - Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.
AU  - Murata Y
AU  - Tanzawa S
AU  - Misumi T
AU  - Yoshioka H
AU  - Miyauchi E
AU  - Ninomiya K
AU  - Takeshita M
AU  - Ito K
AU  - Okamoto T
AU  - Sugawara S
AU  - Kawashima Y
AU  - Hashimoto K
AU  - Mori M
AU  - Miyanaga A
AU  - Hayashi A
AU  - Tanaka H
AU  - Honda R
AU  - Nojiri M
AU  - Sato Y
AU  - Hata A
AU  - Masuda K
AU  - Kozuki T
AU  - Kawamura T
AU  - Suzuki T
AU  - Yamaguchi T
AU  - Asada K
AU  - Tetsumoto S
AU  - Tanaka H
AU  - Watanabe S
AU  - Umeda Y
AU  - Yamaguchi K
AU  - Kuyama S
AU  - Tsuruno K
AU  - Misumi Y
AU  - Kuraishi H
AU  - Yoshihara K
AU  - Nakao A
AU  - Kubo A
AU  - Yokoyama T
AU  - Watanabe K
AU  - Seki N
PY  - 2023
JO  - JTO clinical and research reports
DO  - 10.1016/j.jtocrr.2023.100593
UR  - https://doi.org/10.1016/j.jtocrr.2023.100593
ER  -

APA

Y, M., S, T., T, M., H, Y., E, M., K, N., M, T., K, I., T, O., S, S., Y, K., K, H., M, M., A, M., A, H., H, T., R, H., M, N., Y, S., A, H., K, M., T, K., T, K., T, S., T, Y., K, A., S, T., H, T., S, W., Y, U., K, Y., S, K., K, T., Y, M., H, K., K, Y., A, N., A, K., T, Y., K, W., & N, S. (2023). Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2023.100593

Source records